Pancreatic ductal hyperplasia/dysplasia with obstructive chronic pancreatitis: an association with reduced pancreatic weight in type 1 diabetes
KeywordsEpithelial hyperplasia GAD antibodies LADA Pancreas weight Pancreatic duct Slowly progressive IDDM Type 1 diabetes
Acute-onset type 1 diabetes
Ductal epithelial hyperplasia/dysplasia
Japan Diabetes Society
Slowly progressive insulin-dependent diabetes mellitus
To the Editor: The report by Campbell-Thompson and colleagues , providing evidence that pancreatic weight is reduced irrespective of duration in type 1 diabetic donors, presented important characteristics of the pancreas in type 1 diabetes. We would like to offer two comments and introduce our own results.
First, the report by Campbell-Thompson et al  did not address potential differences in pancreatic weight in terms of subtypes of type 1 diabetes. Two clinical subtypes of type 1 diabetes, the classical acute/rapid-onset form (AT1D) and slowly progressive insulin-dependent diabetes mellitus (SPIDDM; now better known as latent autoimmune diabetes in adults [LADA] ), have been classified by a WHO consultation  and numerous studies, and diagnostic criteria for SPIDDM have been established by the Japan Diabetes Society (JDS) . In the Campbell-Thompson study  the data on the two type 1 diabetes subtypes were potentially conflated with the result that data on pancreatic weight became less specific. We previously reported that the pancreases of patients with SPIDDM [5, 6] had a high frequency of reduced pancreas size and characteristic pancreatic ductal changes (cystic lesions or dilation and narrowing of pancreatic ducts), both of which are associated with pancreatic weight, while the pancreases of patients with classical AT1D did not .
Second, the Campbell-Thompson paper  argued that pancreases with reduced weight had lobular differences; this is related to currently disputed issues including lobular atrophy and exocrine inflammation in type 1 diabetic donor pancreases [7, 8]. Campbell-Thompson’s report  prompted us to study not only pancreatic weight but also pancreatic ductal changes, which are closely related to pancreatic lobular changes, in autopsied pancreases from individuals with the two subtypes of type 1 diabetes, SPIDDM and AT1D.
Eleven pancreases from autopsied SPIDDM patients (M/F, 5/6; age, 64 ± 14 years; range, 42–87 years; duration of diabetes, 13 ± 7 years; range, 0.3–24 years), ten pancreases from AT1D patients (M/F, 5/5; age, 60 ± 9 years; range, 42–74 years; duration of diabetes, 26 ± 11 years; range, 13–47 years), 15 pancreases from patients with type 2 diabetes (M/F, 11/4; age, 72 ± 14 years; range, 43–92 years; duration of diabetes, 13 ± 8 years; range, 3–28 years), and 19 pancreases from patients without diabetes (M/F, 10/9; age, 66 ± 6 years; range, 53–82 years) were reviewed. All donors were of Japanese ethnicity. Pancreases from heavy alcohol users and patients who had a history of DPP-4 inhibitor use and/or pancreatic tumours were excluded from the study. All SPIDDM cases were positive for GAD autoantibodies (mean titre, 56.9 U/ml; range, 3.4–398.0 U/ml; normal, <1.5 U/ml) and were treated with insulin. Their data met the JDS diagnostic criteria for SPIDDM . Pancreatic tissue acquisition and data collection were performed between 1982 and 2014. The autopsied samples were obtained from Toranomon Hospital (Tokyo, Japan), University of Yamanashi (Chuo, Japan) and Saitama Saiseikai Hospital (Saitama, Japan). Tissues from the pancreatic body and tail were formalin-fixed and paraffin-embedded. Written informed consent was obtained from the next of kin on behalf of the autopsied patients. The institutional review boards of the University of Yamanashi and Toranomon Hospital approved all study protocols presented. Fisher’s exact test was used to evaluate the frequencies of lesions. Comparisons between groups were performed using the Kruskal–Wallis test and the Mann–Whitney U test. Values are expressed as mean ± SD.
We found that pancreatic weight was significantly lower in SPIDDM cases than in AT1D cases. A higher frequency of DEHD with lobular atrophy was observed in SPIDDM than in AT1D. Suda et al  showed that DEHD occurs at multiple pancreatic ductal sites with highly viscous mucinous secretions and epithelial cell debris. These mucinous secretions and DEHD frequently obstruct the pancreatic branch ducts and induce obstructive chronic pancreatitis in the upstream pancreatic lobes and lobular atrophy . These characteristic lesions are likely to be related to the reduced weight of the pancreas in SPIDDM and are potentially present in a proportion of patients in Campbell-Thompson’s study . It may be possible that exocrine inflammation induced by DEHD-induced obstructive chronic pancreatitis initiates activation of autoreactive T cells to islet cells with subsequent destruction of beta cells through a bystander mechanism . Our data had limitations due to the small sample size. Further study on the detailed immunological mechanism(s) of chronic obstructive pancreatitis-induced beta cell destruction will be needed.
We wish to thank T. Maruyama, Saitama Saiseikai Hospital for his generous assistance in obtaining the study samples; and F. Takano, Okinaka Memorial Institute for Medical Research, for her excellent secretarial work.
All authors contributed to conception, planning of the study, acquisition of data, analysis and interpretation of data, drafting and critically revising the manuscript. All authors approved the final version to be published. TK is the guarantor of this work and takes responsibility for the integrity of the data and the accuracy of the data analysis.
This work by the authors was funded by grants from the Okinaka Memorial Institute for Medical Research and from the Ministry of Education, Science, Sports and Culture, Japan.
Duality of interest
The authors declare that there is no duality of interest associated with this manuscript.
- 4.Tanaka S, Ohmori M, Awata T et al (2015) Diagnostic criteria for slowly progressive insulin-dependent (type 1) diabetes mellitus (SPIDDM) (2012): report by the Committee on Slowly Progressive Insulin-Dependent (Type 1) Diabetes Mellitus of the Japan Diabetes Society. Diabetol Int 6:1–7CrossRefGoogle Scholar
Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.